The Mount Sinai Skull Base Surgery Center is one of the world's earliest and most distinguished skull base programs, with a long history of advancing the field through the development of modern surgical techniques and publishing outcomes that have helped shape the care of patients worldwide, for even the most challenging skull base conditions. Lead by Raj K. Shrivastava, MD, Director of Skull Base Neurosurgery and George Wanna, MD, MHCM, Director of Skull Base Otolaryngology–Head and Neck Surgery, our multidisciplinary team is dedicated to the diagnosis and treatment of the most complex benign and malignant tumors of the skull base, brain, and pituitary gland.

Built on the pioneering work of Leonard I. Malis, MD, Kalmon D. Post, MD, Joshua B. Bederson, MD, and Eric M. Genden, MD, Mount Sinai has helped define the field of skull base surgery for decades. Today, we continue that legacy by combining exceptional surgical expertise with the latest minimally invasive technologies to deliver the highest level of care for patients with complex skull base disorders.

Our team includes internationally recognized neurosurgeons, otolaryngologists, neurotologists, rhinologists, head and neck surgeons, neuroradiologists, neuro-oncologists, radiation oncologists, endocrinologists, ophthalmologists, neurologists, rehabilitation specialists, and other experts who work together to develop individualized treatment plans. This collaborative approach allows us to provide seamless, coordinated care from diagnosis through recovery.

We treat the full spectrum of skull base and intracranial disorders, including pituitary adenomas and other pituitary tumors, meningiomas, vestibular schwannomas (acoustic neuromas), craniopharyngiomas, chordomas, chordoid tumors, skull base meningiomas, cerebrospinal fluid leaks, trigeminal neuralgia, hemifacial spasm, and other cranial nerve disorders.

Whenever possible, we use advanced minimally invasive techniques designed to improve precision, reduce complications, shorten recovery, and preserve quality of life. Our expertise includes expanded endoscopic transnasal surgery, transorbital, supraorbital endoscopic skull base approaches, microsurgical and keyhole approaches, translabyrinthine approach, retrosigmoid approach, middle fossa approach, endoscopic transcanal approach, stereotactic navigation with advanced 3D surgical planning, intraoperative neurophysiological monitoring (IONM), and other state-of-the-art technologies that improve safety and outcomes.

Patients also benefit from access to cutting-edge clinical research, innovative technologies developed through Mount Sinai BioDesign, and a program that continues to shape the future of skull base surgery through education, research, and surgical innovation.

Whether a patient has a newly diagnosed skull base tumor or has been told their condition is too complex to treat elsewhere, our team offers comprehensive evaluation, expert second opinions, and personalized treatment using the safest and least invasive approach possible.